Abstract LB355: ICP-B794, a B7H3-targeting ADC with a novel linker-payload, demonstrated superior anti-tumor activity and large therapeutic window in preclinical studies
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Beijing InnoCare Pharma Tech Co., Ltd. (China)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154742200
Cites:
Cited by:
Related to:
